10 completed, 1 terminated. 3 Phase 1, 3 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Not applicable | 2 | Completed 2 |
Follow Inflamax Research Incorporated: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Constituents in Exhaled Breath and Room Air From Use of E-vapor Products and Conventional Cigarettes JUUL, VUSE Solo, Conventional Cigarette - Second Hand Tobacco Smoke | Not applicable | Completed | Juul Labs, Inc. | 43 | 2018-09-17 | 2021-06-14 |
| CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes FT21039, FT21041, FT21044 - Smoking | Not applicable | Completed | RAI Services Company | 144 | 2017-03-29 | 2018-04-10 |
| Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations Nicotine Bitartrate Lozenge 4mg, Nicotine Polacrilex 4Mg Lozenge - Safety Issues | Phase 1 | Completed | Niconovum USA | 100 | 2017-03-21 | 2021-01-11 |
| Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16) Tear Film Imager, Low Humidity Environmental Exposure Chamber (LH-EEC) - Dry Eye | Completed | Adom Advanced Optical Technologies Ltd. | 29 | 2017-01-26 | 2017-07-02 | |
| A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL Grass MATA MPL 10200, Grass MATA MPL 18200, Placebo - Allergic Rhinitis | Phase 1 | Completed | Allergy Therapeutics | 29 | 2015-08-01 | 2017-03-03 |
| A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber SQ tree SLIT-tablet, Placebo - Allergic Rhinoconjunctivitis | Phase 2 | Completed | ALK-Abelló A/S | 219 | 2015-06-01 | 2017-01-19 |
| Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC AllerT, Placebo - Allergic Rhino-Conjunctivitis | Phase 2 | Completed | Anergis | 213 | 2014-10-01 | 2015-12-03 |
| Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials Placebo, Allergovit 6-grasses - Allergic Rhinoconjunctivitis, Healthy Volunteers | Phase 2 | Terminated | Allergopharma GmbH & Co. KG | 158 | 2014-01-01 | 2018-01-17 |
| A Study To Investigate The Effects Of A Low Humidity Environment And Visual Tasking On Tear Film Protein Composition Dry Eye | Completed | Inflamax Research Incorporated | 16 | 2013-11-01 | 2013-12-09 | |
| ToleroMune House Dust Mite Follow on Study House Dust Mite Allergy, Rhinoconjunctivitis | Completed | Circassia Limited | 105 | 2013-09-01 | 2014-05-15 | |
| Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch Rotigotine Transdermal System - Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch | Phase 1 | Completed | Inflamax Research Incorporated | 260 | 2013-08-01 | 2016-04-04 |
Dry Eye Syndromes (2) · Dust Mite Allergy (1) · Rhinitis, Allergic (1) · Smoking (1) · Vaping (1)
Tobacco Use Cessation Devices (1) · rotigotine (1)
Canada (7) · United States (4)
Peter Couroux, MD (3) · Frank Lee, MD (1) · Frank Lee, MD, CPI (1) · Margarita Nunez, MD (1) · Piyush Patel, Dr. (1) · Tim Higenbottam, DSc MD FRCP FFPM (1)